SEPJF yields 2.17% · JNJ yields 2.13%● Live data
📍 SEPJF pulled ahead of the other in Year 1
Combined, SEPJF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SEPJF + JNJ for your $10,000?
Spectris plc manufactures and sells measuring instruments and controls worldwide. It operates through Malvern Panalytical, HBK, Omega and Industrial Solutions segments. The Malvern Panalytical segment provides measurement and materials characterization and efficiency in R&D and manufacturing sectors. The HBK segment offers differentiated sensing, testing, modelling and simulation solutions for product development. The Omega segment provides process improvement, specialist sensors, and omni-channel distribution services. The Industrial Solutions segment operates high-value precision in-line sensing and monitors businesses. It also provides particle measuring systems, a solution to measure and monitor contamination levels in clean and controlled environments. In addition, the company offers red lion controls, an industrial automation tool that provides solutions to connect, monitor, and control disparate assets, as well as provides servomex, a specialist in gas and moisture analysis solutions. Further, it provides data and insights, test equipment and software for industrial applications. Additionally, the company offers sensor, instrument, software, and services technology, as well as provides training, technical support, spare parts, calibration, and maintenance services. It serves pharmaceutical, automotive, electronics, semiconductors, technology-LED, and primary and advanced materials industries. Spectris plc was incorporated in 1986 and is based in London, the United Kingdom.
Full SEPJF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.